Glucopyranosylidene-spiro-1,4,2-oxathiazoles were prepared in high yields by NBS-mediated spiro-cyclization of the corresponding glucosyl-hydroximothioates. In an effort to synthesize analogous glucopyranosylidene-spiro-1,2,4-oxadiazolines, with a nitrogen atom instead of the sulphur, attempted cyclizations resulted in aromatization of the heterocycle with opening of the pyranosyl ring. Enzymatic measurements showed that some of the glucose-based inhibitors were active in the micromolar range. The 2-naphthyl-substituted 1,4,2-oxathiazole displayed the best inhibition against RMGPb (K i = 160 nM), among glucose-based inhibitors known to date.
Introduction
Type 2 diabetes mellitus 1 is currently estimated to affect more than 5% of the adult population in Western societies, and its inci-
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dence is expected to increase considerably in the future. 2, 3 This is in particular due to the dramatic increase in obesity even among young adults and children. [4] [5] [6] Striking enhancements in the prevalence of the disease is predicted for the developing countries of Africa, Asia, and South America. 2 Current preventive and therapeutic strategies do not achieve adequate control of blood glucose to diminish chronic morbidity, and there is a need to develop novel healthcare interventions to address this substantial biomedical challenge. 7 Hepatic glucose output is elevated in type 2 diabetic patients 60 and current evidence indicates that glycogenolysis (release of monomeric glucose from the glycogen polymer storage form) is an important contributor to the abnormally high production of glucose by the liver. Glycogen phosphorylase (GP) is the rate limiting enzyme in the liver responsible for glycogen breakdown to produce glucose and related metabolites for energy supply. 8 Due to its key role in modulation of glycogen metabolism, pharmacological inhibition of GP has been regarded as an effective therapeutic approach to treating type 2 diabetes. [9] [10] [11] Several types of compounds for inhibition of GP have been re-70 ported, [10] [11] [12] [13] and among them derivatives of D-glucose represent, as ligands of the catalytic site, the most populated class (Chart 1). [12] [13] [14] [15] There are three mammalian GP isoenzymes termed as 'brain', 'muscle', or 'liver' GP depending on the tissue in which they are preferentially expressed. All isoenzymes can be converted from the inactive form (GPb) into the active GPa form through the phos- 
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phorylation of Ser-14. Isoforms of GP can be obtained from rabbit squeletal muscles (RMGPa/RMGPb) or human liver (HLGPa/ HLGPb). Because of a $80% homology between the liver and muscle isoforms of GP, it is a general practice to use the more readily 80 available RMGP (most frequently in the unphosphorylated b form) for preliminary kinetic studies (Chart 1), even though, for in vivo experiments, the existence of isoforms raises the question of the selectivity of inhibition. 13 The functional form of GP is a homodimer having a C-2 symmetry. The catalytic site of GP is buried at the centre of the monomers, and is accessible to the bulk solvent through a 15 Å long channel. The site has been extensively investigated with glucose analogue inhibitors which promote the less active T (tensed) state through stabilisation of the closed position of the 280s loop. Upon transition from the T state to the R (relaxed) 90 state, the 280s loop becomes disordered and displaced, resulting in the activation of the enzyme. Crystallographic investigations have shown the existence of an empty pocket in the direction of the b-anomeric substituent of D-glucopyranose, lined by both polar and non-polar group, and named the b-channel.
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N-Acetyl-b-D-glucopyranosylamine 16 A was one of the first efficient glucose analogue inhibitors of GP. A large array of compounds with the N-acyl-b-D-glucopyranosylamine structure (e.g., B-F) was synthesized, tested, and also investigated by X-ray crystallography. 10 These studies revealed that a H-bridge between the amide 100 NH and main chain CO of His377 (Chart 1) significantly contributed to the binding. This H-bridge was also observed in GP crystal complexes of the low micromolar inhibitor spiro-hydantoins G 17 and H, 18 and was, thereby, considered to be an essential feature for strong inhibition. The rigidity of the spiro-bicyclic structure of the latter compounds with a pyranoid sugar and a five-membered heterocyclic ring was also considered to be a decisive factor for the efficiency. 17 On the other hand, N-b-D-glucopyranosyl-N 0 -acyl ureas 12, 13, 19 (e.g., I-M) with large aromatic acyl moieties (K, M) properly oriented so as to interact with the side chains of the so-called 110 b-channel next to the catalytic site, exhibit nanomolar inhibition 12, 13, 20 despite the lack of the H-bond mentioned above. Therefore, interactions in the so called b-channel of the enzyme must play a more important role than that particular H-bond. Based on the binding peculiarities of these inhibitors, we envisaged to prepare compounds which might unify the structural features of the best inhibitors, that is, spiro junction between the anomeric carbon of D-glucopyranose and a five-membered hetero- 
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cycle, as well as a large aromatic substituent capable of interactions in the b-channel. This design was supported by the finding that spiro-oxathiazole N, available from earlier synthetic studies, 21, 22 proved to be a micromolar inhibitor. Therefore, synthesis of further compounds of this series was carried out 23 and, in order to facilitate the formation of an additional H-bond, preparation of spiro-oxadiazolines of type O was also attempted.
Results and discussion

Preparation of glucosyl-hydroximothioates
The D-glucosyl hydroximothioates 1a-j were prepared from per-O-acetylated 1-thio-b-D-glucopyranose and in situ formed nitrile oxides used in slight excess (1.2 equiv), following a procedure 130 reported previously by Rollin 32 (Scheme 1, Table 1 ). The synthesis of 1i (Ar = 4-pyridyl) was optimized by increasing the amount of 4-pyridyl-hydroximoyl chloride used for producing the corresponding nitrile oxide with yields growing as follows: 6% (1.4 equiv), 48% (3.8 equiv), 78% (5 equiv). The prepared hydroximothioates which appeared to be stable under normal conditions were deacetylated by standard procedures (NaOMe/MeOH or MeOH/H 2 O/Et 3 N) to afford the corresponding unprotected products in high yields (Scheme 1).
In an attempt to prepare molecules susceptible to bind more 140 tightly at the active site of GP through non covalent interactions involving a polar group near the anomeric center of the ligand, we tried to oxidize compound 1i (Ar = 4-pyridyl) with m-CPBA, as applied earlier for the synthesis of glucosyl-phenyl-sulfoxides. 33 The oxidation was not selective, since the reaction mixture was shown by TLC to contain a mobile compound, and two major polar products. One of them was shown to be the N-oxide 1j (Ar = 4-pyridyl-N-oxide), isolated in ca 30% yield.
NBS-mediated cyclization of hydroximothioates
The spiro-cyclization of phenyl hydroximothioate 1a proceeded Treatment of 1i with NBS (2 equiv) in boiling chloroform for 30 min resulted in the formation of two major and two minor compounds (TLC). Column chromatography afforded only one homogeneous fraction identified as (1R)-3i (30%), based on NMR data and the fact that (1R)-epimers were found to be significantly more dextrorotatory than the (1S)-epimers. 22, 33 Since spiro-cyclization afforded in this case a higher proportion of the (1R)-epimer, we wondered whether this was due to the basic properties of pyridine.
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Therefore, the spiro-cyclization of 1a (Ar = phenyl) was carried out in the presence of DBU (1 equiv) affording 2a (34% yield) in a 1:1 (1S)/(1R) ratio after repeated column chromatographies. As compared to the selectivity normally observed (60% yield, 5:1 (1S)/ (1R) ratio), this change suggested a variation along the possible reaction pathways. The Zemplén deacetylation was achieved in high yields to obtain the desired spiro-oxathiazoles 4b,c,e,g,h. The final products had a very poor solubility in H 2 O, MeOH, EtOH (less than 0.1 mg/ mL) but were soluble in DMF or DMSO. lated b-D-glucopyranosyl azide 7 was transformed into the corresponding phosphinimine derivative 37 which reacted readily with hydroximoyl chlorides [38] [39] [40] and gave the target molecules 8a-c,h.
The NMR spectra of the crude products indicated the presence of two species ($1:10 ratio) assumed to be the E and Z-configured isomers. Due to the poor stability of some of these compounds, only 8b and 8c could be deacetylated by the Zemplén method to give 9b and 9c. The oxidative photocyclization of 4-nitrobenzamidoxime 8b was carried out under conditions similar to those applied in the 210 synthesis of spiro-oxathiazoles 3. A chloroform solution of 8b and NBS was irradiated with a heating lamp (60 or 375 W). NBS (4 equiv, twice as much as for the oxathiazoles) had to be added at once or portion wise to completely transform the starting material. Three experiments afforded mixtures which did not contain the expected spiro-molecule IV (Scheme 2) but separation by column chromatography afforded 10b, 11b, and 12b in variable proportions (Table 2 ). Nitroso compound 10b should result from 8b by oxidation without cyclization. However, formation of 11b and 12b clearly indicated that spiro-cyclization must have occurred 220 followed by ring opening of the pyranosyl ring to allow aromatization of the oxadiazole ring. Compound 12b displayed in addition a carbonyl due to oxidation of the liberated hydroxyl at C-5. The product distribution was highly dependent on the applied conditions which were not optimized, although it was possible to obtain 12b as a single product. tions from attempted spiro-cyclization of benzamidoximes.
Inhibition of glycogen phosphorylase
Enzymatic tests (Table 3) with deprotected hydroximothioates 2, benzamidoximes 9b,c, and the (1R)-configured spiro-oxathiazole (1R)-4i showed no significant inhibition of rabbit muscle glycogen phosphorylase (RMGP) b. In contrast, several (1S)-configured spirocompounds (1S)-4 showed inhibition in the low micromolar range, except for compounds (1S)-4b,c having polar substituents (4-nitro and 4-cyano, respectively). The most efficient was the 2-naphthyl derivative (1S)-4h with a nanomolar K i which appears to be the 260 best glucose-based inhibitor known at the moment. This shows conclusively that a rigid spiro-bicyclic structure, attached to a properly oriented large apolar aromatic group as the 2-naphthyl are favorable structural features for strong binding at the catalytic site of GP. Further exploitation of these findings is in progress for the design of more potent inhibitors.
Conclusion
The recent identification of glycogen phosphorylase as a biological target for the treatment of hyperglycemia led to the design of a large collection of glucose-based inhibitors displaying inhibitory 270 activities in the micromolar range. 10, [12] [13] [14] [15] Among them, the glucopyranosylidene-spiro-hydantoins [28] [29] [30] and N-acyl-N 0 -b-D-glucopyranosyl urea 20, 31 derivatives were shown to be the best inhibitors. Table 2 . 
Based on the binding peculiarities of these types of inhibitors as revealed by X-ray crystallography, we set up a new design principle towards better inhibitors. 23 To validate this approach, we designed a synthesis of properly substituted glucopyranosylidene-spirooxathiazoles by NBS-mediated spiro-cyclization at the anomeric center of glucopyranosyl-hydroximothioate precursors. Attempted preparations of the corresponding aza-analogs, in which the sul-phur atom is replaced by a nitrogen, failed and led to heteroaromatic structures with an acyclic carbohydrate moiety. The 2-naphthyl substituted glucopyranosylidene-spiro-oxathiazole displayed the strongest inhibition with a K i value of 160 nM. The present study provides the best inhibitor of GP in the glucose-based family and strengthens the need for additional investigations towards inhibition of this enzyme. 13 C NMR spectra were recorded at 23°C using Bruker DRX300 or DRX500 spectrometers with the residual solvent as the internal standard. The following abbreviations are used to explain the observed multiplicities: s, singlet; d, doublet; dd, doublet of doublet; ddd, doublet of doublet of doublet; t, triplet; td, triplet of doublet; q, quadruplet; m, multiplet; br, broad; p, pseudo.
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Structure elucidation was deduced from 1D and 2D NMR spectroscopy which allowed, in most cases, complete signal assignments based on COSY, HSQC, and HMBC correlations. Atom numbering follows that of the parent carbohydrate for the description of the sugar signals in the NMR spectra. Uncertain assignments are indicated by an asterisk. NMR solvents were purchased from Euriso-Top (Saint Aubin, France). HRMS (LSIMS) mass spectra were recorded in the positive mode using a Thermo Finnigan Mat 95 XL spectrometer. MS (ESI) mass spectra were recorded in the positive mode (unless stated otherwise) using a Thermo Finnigan LCQ spectrometer. Optical rota-320 tions were measured using a Perkin Elmer polarimeter. A collection of compounds 1 and 2 have been previously described except for their 13 C NMR data. 32 1-Thio-b-D-glucopyranosyl hydroximothioates 2a,b,d,e were previously reported. 32 Compound (1S)-3d was previously reported. 
General procedure B for the preparation of deacetylated compounds 2i and (1R)-4i
The acetylated compound (0.25 mmol) was dissolved in a mixture of water (5 mL), MeOH (5 mL) and triethylamine (1 mL). After stirring overnight at room temperature, TLC showed deacetylation 340 was complete. Evaporation of the volatiles under reduced pressure afforded a residue corresponding to pure deacetylated product.
General procedure C for the preparation of spirooxathiazoles 3
A solution of hydroximothioate 1 (1 mmol) and N-bromosuccinimide (2 mmol) in CCl 4 (20 mL, for 3b-e,g,h) or CHCl 3 (20 mL for 3a,f,i) was boiled and illuminated by a 60 W heat lamp for 45 min. The reaction was diluted with EtOAc (150 mL) and the organic layer was washed with 5% aqueous Na 2 SO 3 (2 Â 100 mL) and water (2 Â 100 mL), dried (Na 2 SO 4 ), filtered and evaporated under Table 3 Inhibition of rabbit muscle glycogen phosphorylase (RMGP) b
No inhibition at 625
No inhibition at 312.
No inhibition at 625 (1S)-4h
No inhibition at 625 
reduced pressure. The residue was purified by flash column chromatography (PE then PE/EtOAc 65:35) to afford the desired acetylated spiro-oxathiazole 3.
General procedure D for the Zemplén deacetylation
A solution of an acetylated compound 1 or 3 (150 mg) and NaOMe (5 mg) in MeOH (15 mL) was stirred at rt for 3 h. The reaction was neutralized to pH 5-6 with Amberlite IR-120 resin (H + form) and the resin washed with MeOH (2 Â 10 mL). The filtrate was evaporated under reduced pressure to afford the desired hydroximothioates 2 and spiro-oxathiazoles 4, respectively. 360 4.1.5. General procedure E for the synthesis of N-glycosylamidoximes 8
Trimethyl phosphine (2.68 mL, 1 M in toluene) was added with stirring to a solution of 2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl azide 7 (1 g, 2.68 mmol) in dry dichloromethane (10 mL). After gas evolution had ceased and TLC showed complete transformation of the starting azide 7 (10-15 min), a hydroximoyl chloride (1 equiv) was added. After 20-30 min, the reaction mixture was poured into water, and the organic layer was separated. The aqueous layer was extracted with dichloromethane (2 Â 20 mL). The or-370 ganic layers were combined, washed with 10% aq sodium carbonate and water (5 Â 20 mL), dried (Na 2 SO 4 ), filtered and evaporated. The residue was purified by flash column chromatography (EtOAc/hexane, 1:3) or crystallization. An optimized synthesis of 8c is also presented below. After the dark brown solution was stirred for 30 min at room temperature, the reaction was finished (TLC). The mixture, diluted with dichloromethane (25 mL), was washed with a satd aq NaHCO 3 solution (25 mL), then with water (25 mL). The organic layer was dried (MgSO 4 ) and concentrated under reduced pressure to afford a crude yellow oil (245 mg) which was subjected to column chromatography (PE/ 
Synthesis of O-peracetylated hydroximothioates
1 4.2.1. 2,3,4,6-Tetra-O-acetyl-1-S-(Z)-4-nitrobenzhydroximoyl-1- thio-b-D-glucopyranose 1b From tetra-O-acetyl-1-thio-b-D-4.2.2. 2,3,4,6-Tetra-O-acetyl-1-S-(Z)-4-cyanobenzhydroximoyl- 1-thio-b-D-glucopyranose 1c From tetra-O-acetyl-1-thio-b-D-EtOAc 2:3 gradually changed to 0:1, with 0.1% Et 3 N) to afford an orange-colored solid. After treatment of a dichloromethane solution with charcoal, 1i was obtained a white solid upon filtration and evaporation (112 mg, 0.23 mmol, 78% yield).
1-S-(Z)-4-Cyanobenzhydroximoyl-1-thio-b-D-glucopyranose 2c
From 
1-S-(Z)-(4-Phenyl)-benzhydroximoyl-1-thio-b-D-glucopyranose 2g
From compound 1g (300 mg, 0.53 mmol) according to general procedure D yielding (190 
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1-S-(Z)-Isonicotinoyl-hydroximoyl-1-thio-b-Dglucopyranose 2i
A solution composed of 1i (90 mg, 0.18 mmol) in a mixture of MeOH (2 mL), water (2 mL) and NEt 3 (0.4 mL) was treated according to general procedure B. A solution composed of 1h (655 mg, 1.23 mmol) and NBS (437 mg, 2.46 mmol) was treated according to the general procedure C to afford a first crop of pure (1S)-3h (181 mg) as a white foam and an additional crop (160 mg) of a mixture of (1S)-3h and (1R)-3h in a 1:2 ratio, respectively. The calculated yields were, respectively, 36% and 16% for the (1S)-and (1R)-epimers.
A solution composed of 1i (636 mg, 1.31 mmol) and NBS (467 mg, 2.62 mmol) in anhydrous chloroform (30 mL) was treated 740 with for 30 min according to the general procedure C. TLC monitoring showed the appearance of two main products (more mobile than 1i) and two minor products. Workup and flash chromatography with petroleum ether EtOAc (containing 0.1% Et 3 N) 7:3 then 2:3 afforded a mixture (107 mg) with 3 components (NMR) some being brominated (as shown by TLC using a specific staining reagent with fluorescein), and (1R)-3i (190 mg, 0.39 mmol, 30% yield) as a transparent solid which appeared labile at room temperature and was kept at 0°C. Optimised synthesis of 8c: 2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl azide 7 (100 mg, 0.26 mmol) was dissolved in dry dichloromethane (1 mL) and trimethyl phosphine (0.268 mL, 1 M in 880 toluene) was added with stirring. During gas evolution, the reagent solution was freshly prepared by adding triethylamine to a solution of p-cyanophenyl hydroximinoyl chloride (153 mg, 0.26 mmol) in dry dichloromethane (1 mL) causing the formation of triethylamine hydrochloride precipitate. When TLC showed complete transformation of the starting material 7 ($15 min), the reagent solution was added to the mixture. After 10 min, the reaction mixture was poured into water and was worked up as described in general procedure E to afford 8c (78 mg, 60% yield).
[a] D +9. A few drops of NaOMe (2.5 M in MeOH) were added to a solution of 8b (100 mg, 0.19 mmol) in dry methanol (7 mL Photolysis of 8b with a 60 W heating lamp using 4 equiv of NBS in one portion: A solution of 8b (200 mg, 0.39 mmol) in dry chloroform (8 mL) was placed in a 100 mL erlenmeyer flask equipped 940 with a reflux condenser and NBS (278 mg, 1.56 mmol) was added in one portion. The mixture was irradiated with a 60 W white heating lamp from a distance of 1 cm. After 15 min, chloroform was added (30 mL), the mixture was washed with 5% aq Na 2 SO 3 , satd aq NaHCO 3 and water. The organic layer was dried (Na 2 SO 4 ), filtered and the solvent was removed under vacuo. The residue was purified by column chromatography (EtOAc/hexane, 1:4) affording 10b as syrup in 30% yield (58 mg). Traces of 12b ($3%) were also detected in the crude product by NMR spectroscopy. Photolysis of 8b with a 375 W heating lamp using 4 equiv of NBS in one portion: A solution of 8b (200 mg, 0.39 mmol) in dry chloroform (12 mL) was placed in a 100 mL erlenmeyer flask equipped with a reflux condenser and NBS (278 mg, 1.56 mmol, 4 equiv)
was added in one portion. The mixture was irradiated with a 375 W white heating lamp from a distance of 1 cm. After 2 h, the mixture was diluted with chloroform (30 mL), washed with 5% aq Na 2 SO 3 , satd aq NaHCO 3 Photolysis of 8b with a 60 W heating lamp using 4 equiv of NBS in 4 portions: A solution of 8b (1 g, 1.96 mmol) in dry chloroform (40 mL) was placed in a 250 mL erlenmeyer flask equipped with a reflux condenser and NBS (348 mg, 1.96 mmol, 1 equiv) was 990 added. The mixture was irradiated with a 60 W white heating lamp from a distance of 1 cm. After 30 min, NBS (348 mg, 1.96 mmol, 1 equiv) was added to the reaction mixture. An additional 2 equiv of NBS were added in two portions after 105 min and 135 min, respectively. After 2 h 45 min total reaction time, the mixture was diluted with chloroform (120 mL), washed with 5% aq Na 2 SO 3 , satd aq NaHCO 3 and water. The organic layer was dried (Na 2 SO 4 ), filtered and the solvent was removed under vacuo. The residue was purified by column chromatography (EtOAc/hexane, 1:4) affording 12b as a sole syrupy product in 45% yield (447 mg). A solution of Et 3 N (240 lL, 1.72 mmol, 12 equiv) in toluene (2 mL) was added dropwise over 8 h (syringe pump) to a solution of hydroximolactone 13 (80 mg, 0.14 mmol) and a-chloro-p-methoxybenzaldoxime (210 mg, 1.15 mmol, 8 equiv) in refluxing toluene (15 mL). After 24 h reflux, TLC showed a partial conversion of 13 into several products. After concentration, the residue was purified by column chromatography (PE/EtOAc, 7:3) to afford unre-1020 acted 13 (33 mg) then 15 (13 mg, 13% isolated yield). Based on the converted starting material, the calculated yield was 22%. 
Enzymatic methods
Glycogen phosphorylase b was prepared from rabbit skeletal muscle according to the method of Fischer and Krebs, 45 using dithiothreitol instead of L-cysteine, and recrystallized at least three times before use. Kinetic experiments were performed in the direc-1040 tion of glycogen synthesis as described previously. 18 Kinetic data for the inhibition of rabbit skeletal muscle glycogen phosphorylase were collected using different concentrations of a-D-glucose-1-phosphate (2-20 mM), constant concentrations of glycogen (1% w/v) and AMP (1 mM), and various concentrations of inhibitors. Inhibitors were dissolved in dimethyl sulfoxide (DMSO) and diluted in the assay buffer (50 mM triethanolamine, 1 mM EDTA and 1 mM dithiothreitol) so that the DMSO concentration in the assay should be lower than 1%. The enzymatic activities were presented in the form of double-reciprocal plots (Lineweaver-Burk) 1050 applying a nonlinear data analysis program. The inhibitor constants (K i ) were determined by Dixon plots, by replotting the slopes from the Lineweaver-Burk plots against the inhibitor concentrations. 26, 30 The means of standard errors for all calculated kinetic parameters averaged to less than 10%. 
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